| No. | Counters | No. of Shares | Market Price | Total Value (SGD) | Allocation % |
| 1. | Alibaba | 3,200 | USD 100 | SGD 435,200 | 32% |
| 2. | Tencent | 5,500 | HKD 418 | SGD 390,830 | 29% |
| 3. | Alphabet | 500 | USD 202 | SGD 137,360 | 10% |
| 4. | Ping An | 18,000 | HKD 43.5 | SGD 133,110 | 10% |
| 5. | IShares HSTech | 33,000 | HKD 10.4 | SGD 58,344 | 4% |
| 6. | Broadcom | 200 | USD 218 | SGD 59,296 | 4% |
| 7. | AMD | 235 | USD 115 | SGD 36,755 | 3% |
| 8. | Celsius | 500 | USD 23.9 | SGD 16,250 | 1% |
| 9. | SG Stocks | – | – | SGD 93,357 | 7% |
| Total | SGD 1,360,502 | 100% |
Happy New Year!
It feels like forever since the last round I provided this sort of portfolio update back in 2023, and I thought with the blog being stagnant for a while now, I could do a quick update.
For very obvious reasons, the portfolio remained very heavily concentrated towards the HK and China market, and I have not been able to diversify much due to the stocks still being very much in the lower dundrum part of the whole equation.
Chinese stocks to date still weighted heavily at 75% concentration while I was able to diversify a bit out to the US market with concentration coming in at 18%. The rest of the 7% belongs to the SG market, which at some point I do intend to keep it above 10%.
I did some clear out from my last update which I will not be updating in detail, and some of them clearly made a significant amount of losses, offset by the recent gains which I managed to further add to the account.
I continued to remain active in my options play which have given me quite a bit of good additions in replacement of dividends, which I do intend to increase a bit more allocation towards these areas as I get to eventually cash out more on the Chinese stocks.
For SG portfolio, they are mostly carried by the strong performance of the banks in recent years and hence it managed to edge out a good amount of decent dividends in the past year. Going forward, I do have intentions to add a bit more Reits play with the likes of Link Reit as well as CICT to the portfolio to increase the dividend yield of the portfolio.
For some house order in the earlier days of the year, I continued to pump in aggressively towards the voluntary contribution to the Medisave account for both last year and this year as I needed some ways in order to get my tax reduced in a more efficient ways – now that the FRS goal has been achieved.
Another thing which may be controversial, I have also stopped contributing my OA towards the mortgage payment and I have since last year paid my full mortgage monthly payment now in cash, as I see this as a forced saving towards equity + OA growth in CPF. When the time is right, the amount in the OA could serve well should market gives the right opportunity to dive on.
Not much, but I have also started contributing to SRS, another of tax deduction and retirement tool from last year onwards. For this SRS amount, I have used Endowus to invest the money in the money market and funds from the US.
So that’s all the update I have for now, I will see if anything warrants another update sometime in the future when I have more time to do so or if there are significant changes that I am making towards money portfolio management. Until then.
